baber/WOPTO huggingface dataset:
Patent FI-956296-A0 (FI)
Inventor: SALO MARKKU
IPC: D21H23/32
Filed: 1995-12-28
Abstract: The invention concerns an applicator device for application of a coating agent onto a moving base, such as a paper or board web, onto the face of a film press roll, or equivalent. The applicator device (40) comprises an applicator beam (40), which is placed in the direction transverse to the running direction of the moving base (B) to be coated and on whose support the coating-agent feed pipe (52) placed in the cross direction of the machine and/or equivalent coating-agent feed devices as well as a coating head, a nozzle device or equivalent (53,54,55) are mounted, said coating head or equivalent being fitted to spread and to smooth the coating agent onto the moving base (B). The coating-agent feed pipe (52) and/or the equivalent coating-agent feed devices as well as the coating head, the coating-agent nozzle device or the equivalent coating-agent spreading and smoothing equipment (53,54,55) have been constructed as a single unit (50). Said unit (50) has been mounted on the applicator beam (40) by means of a joint (60a), which permits relative movements arising from thermal expansion or equivalent between the applicator beam (40) and said unit (50) in the cross direction of the machine while substantially preventing relative movements of the applicator beam (40) and said unit (50) in other directions. <IMAGE>
Patent FI-981429-A0 (FI)
Inventor: HEIKKINEN ANTTI
IPC: D21H23/26
Filed: 1998-06-22
Abstract: In the method for treating the surface of the web, liquid is added on the surface of a paper or paperboard web (W), possibly with other constituents. The absorbency of the surface of the paper or paperboard web is increased before liquid is brought on the surface of the web or simultaneously with bringing the liquid on the surface of the web. The method is used for wetting the surface of the web before calendering, or for coating the web in surface sizing or pigmenting. The absorbency of the surface is increased before bringing the liquid for example by means of a corona treatment, a flame treatment, an ozonization or by adding steam.
Patent IL-59395-A0 (IL)
Title: Deacetoxycephalosporin derivatives and their preparation
IPC: C07D501/20
Filed: 1980-02-15
Abstract: New bromo-substituted deacetoxycephalosporins of the general formula: 
<CHEM>
 wherein R1 represents a benzamido, formamido, phenylacetamido or phenoxyacetamido group, R2 represents a hydrogen or bromine atom and R3 represents a silyl group of the general formula: 
<CHEM>
 wherein R1, R sec  and R''' are the same or different and each represents an alkyl group (having at most 6 carbon atoms), a halogen-substituted alkyl group (having at most 6 carbon atoms) or an aryl group and process for the preparation of the compound of formula I. 
<??>The compounds of formula I are suitable intermediates in processes for the preparation of known or new antibiotics.
Patent IL-78495-A0 (IL)
Title: Leukotriene antagonistic benzyl mercaptan derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07C47/546
Filed: 1986-04-15
Abstract: Intermediates of structure: <CHEM> wherein Y is CO2R10 or CH(R12)CO2R10 in which R10 is an ester protective group and R10 is hydrogen, methyl, methoxy or fluoro, and their use for the preparation of leukotriene antagonists.
Patent IL-81969-A0 (IL)
Title: Crucible for thermal analysis of aluminium alloys
IPC: G01N33/20
Filed: 1987-03-23
Abstract: A crucible for the thermal analysis of aluminum alloys is disclosed. This crucible is charaterized in that the internal surface of at least one of its side walls is at least partially covered with a film of refining agent. The crucible finds application in measuring both the silicon content in and the degree of refining of hypereutectic aluminum-silicon alloys.
Patent IL-83275-A0 (IL)
Title: Piperidine compounds,their preparation and pharmaceutical compositions containing them
IPC: A61K31/44
Filed: 1987-07-21
Abstract: New piperidine compounds having the formula <CHEM>  wherein    at least one of R<3>, R<4>, and R<5> are <CHEM>  and the other independently are H or C1-6-alkyl,   wherein R' is H, C1-8-alkyl, phenyl, thienyl, cyclopropyl, or C1-3-alkoxymethyl; and    R<1> and R<6> independently are H or C1-6-alkyl <CHEM>  and a salt thereof with a pharmaceutically-acceptable acid. The new compounds are useful in improving the cognitive functions of the forebrain and hippocampus of mammals, and are useful in the treatment of Alzheimer's disease.
Patent IL-99912-A0 (IL)
Title: Cyclosporins,their preparation and pharmaceutical compositions containing them
IPC: C12R1/645
Filed: 1991-10-31
Abstract: It has been found that nonimmunosuppressive, cyclophilin-binding cyclosporins are useful in the treatment and prevention of AIDS and AIDS-related disorders. Such cyclosporins include novel Ciclosporin derivatives modified at the 4- and/or 5-positions.
Patent AU-PM523894-A0 (AU)
Title: Refrigeration system
IPC: F25D3/00
Filed: 1994-04-21
Abstract: PCT No. PCT/AU95/00241 Sec. 371 Date Dec. 9, 1996 Sec. 102(e) Date Dec. 9, 1996 PCT Filed Apr. 21, 1995 PCT Pub. No. WO95/29372 PCT Pub. Date Nov. 2, 1995A refrigeration system (12) is comprised of three expansion units (19A, 19B, 19C), with each having an expansion chamber (22) and three secondary chambers (24, 26 and 28), connected to a supply (16) of compressed refrigerant. The expansion chamber and secondary chambers are formed with progressively reducing volumetric capacity. The end of each of the the secondary chambers, is connected to a common bleed tube (29) having a bleed hole (34) for venting the refrigerant. The bleed hole opens to the outside of a housing (15) which houses the expansion units. The interior of the housing (15) is filled with a gel which changes state from a liquid to a solid at a predetemmined temperature. A valving arrangement (32) connects the expansion units to a supply of compressed refrigerant. The housing (15) together with a supply (16) refrigerant can be installed into a cooling box for cooling the space within the cooling box. This is achieved by the valve mechanism (32) periodically admitting a volume of compressed refrigerant into the expansion units, wherein the compressed refrigerant initially expands in the expansion chambers. This in turn absorbs heat from the space within the box. The flow of expanded refrigerant through the secondary chambers is retarded by back pressure produced by having the secondary chambers of progressively reducing volumetric capacity. This allows the gel to be maintained at a frozen state for a long period of time while consuming only small volumes of compressed refrigerant.
Patent FI-20001742-A0 (FI)
Inventor: LINDHOLM CHRISTIAN
IPC: H05K5/02
Filed: 2000-08-03
Abstract: A hinge mechanism for a portable, foldable electronic device (1) comprising two or more positions and comprising at least three housing parts (2, 6, 9) foldable in relation to each other, wherein the hinge mechanism (36) comprises: a hinge system (39), which is arranged to couple the first housing part (6) to the second housing part (9), to fold the first and the second housing parts (6, 9) in relation to each other, and to couple the first and the second housing parts (6, 9) to the third housing part (2) in a foldable manner. The hinge mechanism (36) further comprises an ejector mechanism (37) arranged for moving said hinge system (39) away from the third housing part (2).
Patent FI-20010913-A0 (FI)
Inventor: LINDROOS GUNNAR
IPC: E03C1/12
Filed: 2001-05-03
Abstract: The invention relates to valve means for a flow pipe, the valve means (1) comprising a cylindrical or sleeve like body part (11) having a length (L) which is longer than the extension (I) of a flow opening (4) in the flow pipe (2). The body part (11) is fastenable to the flow pipe (2) or to a branch part (17) of the flow pipe (2) by connecting means (12,13), whereby the connecting means comprises first flange means (12) extending in a first direction of the flow pipe (2) and second flange means (13) extending in a direction opposite to the first direction of the flow pipe (2), said first and second flange means (12,13) being fastened to the body part (11). The body part (11) is made of a flexible structure in order to provide for the valve function in a simple manner. <IMAGE>
Patent FI-20011098-A0 (FI)
Inventor: NAGHIAN SIAMAEK
IPC: H04W28/22
Filed: 2001-05-25
Abstract: A method for deciding on handover in a cellular communication system and a cellular communication system comprising cells (A, B, C, D) and a mobile station (MS 1 , MS 2 , MS 3 ) having a connection to at least a first cell providing a certain data transfer rate i.e. a bit rate to the mobile station, wherein the system is arranged to collect bit rate information related to the mobile station and use the bit rate information for deciding on handover of the mobile station from the first cell to a second cell.
Patent FI-20030748-A0 (FI)
Inventor: LEHTONEN JORMA
IPC: B65G1/04
Filed: 2003-05-20
Abstract: The invention relates to an arrangement (10) in circumferential storage, particularly in connection with a multi-ring store (10.1). The arrangement (10) includes at least one circumferential-store unit (10.1), which comprises several concentric rings (11 - 13) arranged to rotate. The rings can be rotated relative to each other, in such a way that access to at least some of the package locations of the rings is arranged through the other rings (11 - 13). Transferring devices (10.2) are arranged outside the circumferential store unit which are formed of a vertical column structure (14), in connection with which is, a slide arrangement (15) that can be moved vertically, and, in connection with the slide arrangement, a boom element (16), with gripper devices (17) at the end, and which can be moved horizontally. The invention also relates to a transferring device and a method for operating a circumferential store.
Patent FI-20085543-A0 (FI)
IPC: C08J7/043
Filed: 2008-06-03
Abstract: The present invention relates to a release liner composition in which the adhesion of silicone has been improved between a silicone coating and a surface treating layer and so silicone rub-off prevented. The improvement of adhesion is based on a polymeric surface treating agent structure comprising a moiety or moieties that are compatible with a substrate and/or a coating on the surface of the substrate, and a moiety or moieties that are reactive or at least compatible with the silicone coating. The present invention also relates to a base material and a method of producing a base material, and a surface treating agent for a base material and a use of a surface treating agent.
Patent FI-20115704-A0 (FI)
Inventor: JOENSUU JUSSI
IPC: C12P/
Filed: 2011-07-01
Abstract: The present invention concerns a method for improving the expression levels of proteins, wherein hydrophobin fusion proteins are expressed, thereby inducing the formation of protein bodies, and wherein said hydrophobin fusions are co-expressed with a target protein or with a further fusion of the target protein.
Patent IL-108052-A0 (IL)
Title: Treatment of neurological lesions associated with trauma
IPC: A61K9/20
Filed: 1993-12-16
Abstract: PCT No. PCT/FR93/01229 Sec. 371 Date May 30, 1995 Sec. 102(e) Date May 30, 1995 PCT Filed Dec. 10, 1993 PCT Pub. No. WO94/13288 PCT Pub. Date Jun. 23, 1994Application of riluzole or its pharmaceutically acceptable salts in the treatment of neurological lesions related to traumatic injuries, especially spinal, cranial or cranial-spinal injuries.
Patent IL-109090-A0 (IL)
Title: Ptp-s31: a novel protein tyrosine phosphatase
IPC: G01N33/573
Filed: 1994-03-23
Abstract: A novel protein tyrosine phosphatase designated PTP-S31 and its subfamily are identified, as are nucleic acid molecule coding therefor. Included in this family are PTP-S31 proteins or glycoproteins having one, two, or three identified amino acid changes in previously defined consensus sequences in the catalytic phosphatase domains of known protein tyrosine phosphatases. The PTP-S31 proteins or glycoproteins may be produced by recombinant means. Antibodies to PTP-S31 proteins or glycoproteins and nucleic acid constructs coding therefor, and methods for screening molecules which can bind to PTP-S31 proteins or glycoproteins and inhibit or stimulate their enzymatic activity, are provided.
Patent IL-123502-A0 (IL)
Title: Biphenyl hydroxamate inhibitors of matrix metalloproteinases
IPC: C07C259/06
Filed: 1996-11-13
Abstract: Compounds of formula   <IMAGE>   or a pharmaceutically acceptable salt thereof inhibit matrix metalloproteinases and TNF alpha  secretion and are useful in the treatment of inflammatory disease states. Also disclosed are matrix metalloproteinases and TNF alpha  secretion inhibiting compositions and a method for inhibiting matrix metalloproteinases and TNF alpha  secretion.
Patent IL-126073-A0 (IL)
Title: Microencapsulated fluorinated gases for use as imaging agents
IPC: A61K49/00
Filed: 1997-02-27
Abstract: Method for enhancing echogenicity of synthetic polymeric microparticles in ultrasonic imaging, by incorporating a fluorinated gas instead of air in the microparticle, is new. Also claimed is a composition for ultrasound imaging comprising a synthetic biocompatible polymeric microparticle incorporating a fluorinated gas to enhance imaging, and a pharmaceutically acceptable carrier. Also claimed is a method of making a microparticle formed of a biocompatible polymer having enhanced echogenicity, comprising incorporating into a solution of the biocompatible polymer a volatile salt, then removing the polymer solvent and the volatile salt to form the porous microparticle.
Patent IL-136817-A0 (IL)
Title: Lead-free tin projectile
IPC: F42B30/02
Filed: 1998-12-04
Abstract: There is provided a lead-free projectile suitable for use as a bullet to be fired from a pistol or rifle or as a slug to be fired from a shotgun. The projectile core is formed from a high purity tin and has deformation properties similar to that of lead based projectiles without the environmental hazards associated with lead.
Patent IL-143846-A0 (IL)
Title: Dosage forms comprising porous particles
IPC: A61K9/26
Filed: 1999-12-23
Abstract: A dosage form comprising a plurality of particles having interior pores and a liquid, active agent formulation in the pores, the particles being compactable and adapted to retain substantially all of the liquid active agent formulation within the pores during the compacting process, is described. The dosage forms may be in the forms of unitary oral forms for immediate release of active agent, prolonged delivery forms, or controlled delivery forms. All forms involve certain absorbent materials having prescribed characteristics, particularly spray dried calcium hydrogen phosphate and magnesium aluminometasilicate.
Patent IL-150293-A0 (IL)
Title: Cyanomethylene compounds, process for producing the same, and agricultural or horticultural bactericide
IPC: C07D277/10
Filed: 2000-09-05
Abstract: The cyanomethylene compound of the invention is a compound represented by the formula (1) <CHEM> wherein R is C1-20 straight-chain or branched-chain alkyl, C3-8 cycloalkyl, aryl or heterocyclic group; and the aryl and the heterocyclic group may be substituted with one or more substituents); R<1> is C1-8 straight-chain or branched-chain alkyl, C3-8 cycloalkyl, aryl or heterocyclic group; and the aryl and the heterocyclic group may be substituted with one or more substituents; A is C1-6 straight-chain or branched-chain alkylene, and Y is a sulfur atom, sulfinyl or sulfonyl. The cyanomethylene compound of the invention exhibits an excellent fungicidal activity against drug resistant fungi as well as drug sensitive fungi, and can be used as a fungicide in agriculture and horticulture.
Patent IL-150566-A0 (IL)
Title: Nucleic acids and polypeptides and nogo-receptor proteins
IPC: G01N33/566
Filed: 2001-01-12
Abstract: Disclosed are Nogo receptor proteins and biologically active Nogo (ligand) protein fragments. Also disclosed are compositions and methods for modulating the expression or activity of the Nogo and Nogo receptor protein. Also disclosed are peptides which block Nogo-mediated inhibition of axonal extension. The compositions and methods of the invention are useful in the treatment of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease.
Patent IL-152099-A0 (IL)
Title: Synchronization of timing advance and deviation
IPC: H04B7/26
Filed: 2001-04-05
Abstract: A mobile terminal and method for reducing the latency from timing deviation (TD) measurement to time advance (TA) adjustment. The invention uses a deterministic procedure to coordinate time advance (TA) commands and timing deviation (TD) measurements so that failed transmissions or mobile terminals signal propagation changes can be recognized and corrected much more rapidly. Radio resource efficiency is maximized by minimizing signaling overhead through effectively reducing the frequency of time advance commands. This is accomplished by using TA commands signals which include a Connect Frame Number (CFN) to specify particular radio frames for time advance (TA) adjustment. The potential for timing deviation (TD) measurements to be incorrectly processed in conjunction with adjusting a physical reception window and calculating mobile termination location is minimized, without excessive command signaling requirements. <IMAGE>
Patent IL-157380-A0 (IL)
Title: Mediator stabilized reagent compositions and methods for their use in electrochemical analyte detection assays
IPC: G01N33/483
Filed: 2003-08-13
Abstract: A reagent composition comprises an enzyme, redox mediator and mediator-stabilizing buffer to stabilize the redox mediator. Independent claims are also included for the following: (1) an electrochemical cell which comprises a reagent composition; (2) an electrochemical test strip which comprises electrochemical cell; (3) method for making an electrochemical test strip, which involves using reagent composition; (4) a method for determining the concentration of an analyte in a sample, which involves applying the sample to an electrochemical cell, detecting an electrical signal produced by the cell and relating the detected electrical signal to the concentration of the analyte in the sample; (5) kit for determining the concentration of an analyte in a physiological sample, which comprises an electrochemical test strip, and sample obtainment element and an analyte standard; and (6) a system which comprises an electrochemical test strip and meter for reading the test strip.
Patent IL-164018-A0 (IL)
Title: Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa
IPC: C07C235/52
Filed: 2003-03-24
Abstract: The compounds of formula (I) in which R represents a hydrogen atom or a fluorine atom, or a pharmaceutically acceptable salt thereof are Factor Xa inhibitors useful in the treatment of thrombotic disorders.
Patent IL-178747-A0 (IL)
Title: Methods for treatment of certain cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
IPC: A61P29/00
Filed: 2006-10-19
Abstract: Methods of treating, preventing and/or managing cancer as well as diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Patent IL-190656-A0 (IL)
Title: Adjustable vaginal splint for pelvic floor support
Filed: 2008-04-07
Abstract: Vaginal splints and methods for their use for treating various pelvic floor conditions are provided. One embodiment of the vaginal splint includes a base portion having a configuration defined by first and second sides, a first connecting portion at a proximal side of the base portion and extending between a first end of each of the first and second sides, and a second connecting portion at a distal side of the base portion and extending between a second end of each of the first and second sides. The splint further includes an adjustable portion coupled to the base portion and positioned substantially adjacent to and distal of the second connecting portion of the base portion. The adjustable portion is removable by a user to thereby change the size of the splint.
Patent RO-128300-A0 (RO)
Title: Gis2 - system for in vitro simulation of the human colon in three stages
Inventor: VAMANU EMANUEL
IPC: C12M3/00
Filed: 2011-11-17
Abstract: The present invention relates to a method for in-vitro testing the transit effect through the human colon of two probiotic product formulations. According to the invention, the method consists in carrying out the in vitro simulation system, preparing the culture medium with a composition similar with the composition in the colon, preparing the faeces sample for developing the microbiota, carrying out a continuous fermentation for stabilizing the specific microbiota for 48 h, introducing the sample into the ascending colon, the first simulated segment, testing the maintaining of the sample at said level for 4 hours, passing into the transverse colon, the second simulated segment, maintaining the sample at said level for 5 hours, passing into the descending colon, the third simulated segment, maintaining the sample at said level for 4 hours and finally carrying out the microbiological analysis in order to establish the ratio between the different groups of microorganisms in each colon segment.
Patent RO-130427-A0 (RO)
Title: Shelter against earthquakes, tornadoes, hurricanes, tsunami, terrorist attacks, wars, sabotage acts, explosions, floods, landslides, fires and other natural disasters and against thieves, as well
Inventor: CHIRIŢĂ DOREL PETRU
IPC: E04H15/50
Filed: 2014-11-17
Abstract: The invention relates to a shelter against earthquakes, tornadoes, hurricanes, tsunami, terrorist attacks, wars, sabotage acts, explosions, floods, landslides, fires, other natural disasters, as well as against thieves, for saving human lifes. According to the invention, the shelter has the shape of a quadrangular prism with rectangular base, made of steel, which has a sponge mattress (4), a locker (12) consisting of a sanitary kit (36), a mobile phone (37) which is supplied from a motor vehicle-type charger (38) from a battery (17) of 12 V, a dynamo flashlight (39), sugar (40), an oxygen tube (41), a water can (35), dry food (44), a book (45), five screw plugs (34) with seal, some door gaskets (33) meant to prevent water or gas to pervade inside, a door (1) which closes/opens, using some hinges (3) and a lock (2), an opening (5) for the lock, having a clamping rivet (13) with a rod (8), lifted and lowered due to the air in a tube (7) due to a pump supplied from a battery (17) of 12 V, being fastened by means of a housing (6) to the earthquake shelter, having two switches (18 and 19) for air discharge, to allow the closure of the door and the start of pump (16) for introducing the air into the tube (7), a socket (20) for charging the mobile phone (37) from the battery (17) of 12 V, for a tablet computer (29) and a television set (30), a LED bulb (31) and a switch (32), a channel (11) through which the oxygen enters, provided with cone (9) with an axle (9'), which is fastened by means of some plates (9") to a mesh screen (10), and the oxygen entering through a recess (10'), a mesh screen (14), rubber (46) being fixed to some sponges (15) on the entire surface of the shelter, a push-button (21), a housing (22), an axle (23), a spring (24), a stopper (25), oxygen (26), an oxygen discharge channel (28), a toilet (27), some hangers (42) attached with spike nails (43) to the wall.